Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1873 - 1880 of 11449 results
Monthly TCPA Digest — April 2022
April 25, 2022| Article| Viewpoint
TCPA Litigation Update — Eighth Circuit Finds System That Sends Texts to Stored Numbers Is Not an ATDS
April 25, 2022| Article| Viewpoint
Law360's 2022 Life Sciences Editorial Board
April 25, 2022| News
With Proposal to Cap Drug Price Increases, Massachusetts Once Again Takes Center Stage in the Drug Pricing Debate
April 22, 2022| Blog| Viewpoint
Massachusetts Paid Family and Medical Leave Updates – What You Need to Know
April 21, 2022| Blog| Viewpoint
EXCLUSIVE RIGHTS: Intellectual Property — Will the Unified Patent Court Change Everything?
April 21, 2022| Podcast| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.